LabCorp(R) to Offer Liver Fibrosis Assay HCV FibroSure(TM) Through Exclusive Relationship With BioPredictive

Only Noninvasive Option That Quantifies the Degree and Rate of Liver Fibrosis in HCV Patients BURLINGTON, N.C., Oct 21, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America Holdings (NYSE: LH) (LabCorp(R)) and BioPredictive, a French diagnostics firm, today announced an

LabCorp(R) Scheduled to Present at the UBS Global Life Sciences Conference

BURLINGTON, N.C., Sept. 19 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Thomas P. Mac Mahon, Chairman and Chief Executive Officer, is scheduled to speak at the UBS Global Life Sciences Conference in New York, NY, on September

LabCorp(R) Scheduled to Present at The Banc of America Securities Annual Investment Conference

BURLINGTON, N.C., Sept. 15 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Thomas P. Mac Mahon, Chairman and Chief Executive Officer, is scheduled to speak at the Banc of America Securities 33rd Annual Investment Conference in San

LabCorp(R) Scheduled to Present at the Thomas Weisel Partners Health Care Conference

BURLINGTON, N.C., Sept. 3 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Bradford T. Smith, executive vice president of corporate affairs, is scheduled to speak at the Thomas Weisel Partners Health Care Conference in Boston, MA

LabCorp Announces Legal Settlement

BURLINGTON, N.C., Sept. 3 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) announced today the settlement of a lawsuit brought by its subsidiary DIANON Systems, Inc. against five former employees and Diapath LLC.

New PreGen-Plus(TM) Colon Cancer Assay Offered by LabCorp(R) Beginning Today

BURLINGTON, N.C., Aug. 13 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) announced that the PreGen- Plus(TM) colon cancer assay is nationally available for LabCorp's clients to order beginning today. PreGen-Plus(TM) is the proprietary DNA-based stool

Laboratory Corporation of America(R) Announces 2003 Second Quarter Results

Reports EPS of $0.60; Operating Cash Flow Increases 32 Percent to $123 Million; Combined Genomic and Esoteric Testing Revenues Increase 34 Percent BURLINGTON, N.C., July 22 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced results for

LabCorp and Patient Safety Institute Partner to Improve Access to Laboratory Test Results and Preserve Patient Privacy

Alliance Will Leverage Medicity Technology to Serve Patients in the State of Delaware PLANO, Texas and BURLINGTON, N.C., Jul 21, 2003 /PRNewswire-FirstCall via COMTEX/ -- The Patient Safety Institute (PSI) a leader in patient information, safety and healthcare connectivity, and Laboratory

LabCorp(R) Names M. Keith Weikel, Ph.D. to Its Board of Directors

BURLINGTON, N.C., July 18 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that M. Keith Weikel, Ph.D. has been elected to its Board of Directors, effective July 16, 2003. Dr. Weikel, 65, is a Senior Executive Vice President and Chief

LabCorp and Atherotech to Offer VAP Cholesterol Test

BURLINGTON, N.C., Jul 7, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America Holdings (NYSE: LH) (LabCorp(R)) today announced that it has entered into a marketing and distribution relationship with Atherotech, a leading cardiodiagnostic company and specialty reference